ReviewACS omega2026
Research Progress and Application Prospects of Bioaffinity Chromatography in Screening Cardiotoxic Components of Chinese Herbal Medicines.
Review in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
With the continuous expansion of the clinical application of Chinese herbal medicines (CHMs), the cardiotoxicity risk of certain herbs or naturally derived substances traditionally considered "safe" has gradually emerged. This paper systematically explores the potential of bioaffinity chromatography as an efficient screening tool for identifying cardiotoxic components from complex CHM matrices through a literature review conducted across multiple databases using keywords such as "cardiotoxicity," "bioaffinity chromatography," "aconitine," and "bioactivity." The clinical manifestations and molecular mechanisms of CHM-induced cardiotoxicity were first reviewed, focusing on ion channel dysfunction, mitochondrial damage, apoptosis, and metabolic disorders. Subsequently, a detailed discussion of the five main bioaffinity chromatography techniques, including immunoaffinity chromatography, lectin affinity chromatography, cell membrane chromatography, receptor affinity chromatography, and DNA affinity chromatography, was provided, highlighting their principles and applications in screening the bioactivity from herbs. For the first time, it is proposed to apply bioaffinity chromatography technology to screen components in CHMs that have cardiotoxic effects through specific biological interactions. This enables targeted and high-throughput identification of cardiotoxic compounds and highlights its potential in early cardiotoxicity prediction and mechanistic studies. This review aims to provide a methodological framework for shifting the safety evaluation of CHMs from reactive analysis to proactive risk warning, thereby supporting the rational and safe clinical use of CHMs.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.